Madison Elsaadi
Stock Analyst at B. Riley Securities
(4.82)
# 436
Out of 4,423 analysts
49
Total ratings
66.7%
Success rate
63.3%
Average return
Main Sectors:
Stocks Rated by Madison Elsaadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintained: Buy | $31 → $40 | $32.48 | +23.15% | 13 | May 15, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $9 → $10 | $4.07 | +145.70% | 2 | Apr 30, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $37 → $31 | $6.16 | +403.25% | 14 | Apr 30, 2026 | |
| CMPS COMPASS Pathways | Initiated Coverage: Buy | $17 | $12.53 | +35.67% | 1 | Apr 24, 2026 | |
| CAPR Capricor Therapeutics | Rated: Buy | $50 → $63 | $28.38 | +121.99% | 6 | Mar 13, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $5 | $2.27 | +120.26% | 3 | Mar 10, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintained: Buy | $14 → $17 | $5.81 | +192.85% | 4 | Feb 25, 2026 | |
| FENC Fennec Pharmaceuticals | Initiated Coverage: Buy | $16 | $9.06 | +76.60% | 1 | Feb 12, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $61 → $101 | $81.82 | +23.44% | 4 | Jan 22, 2026 | |
| AXSM Axsome Therapeutics | Initiated Coverage: Buy | $179 | $250.50 | -28.54% | 1 | Oct 1, 2025 |
Eton Pharmaceuticals
May 15, 2026
Maintained: Buy
Price Target: $31 → $40
Current: $32.48
Upside: +23.15%
Opus Genetics
Apr 30, 2026
Maintained: Buy
Price Target: $9 → $10
Current: $4.07
Upside: +145.70%
Wave Life Sciences
Apr 30, 2026
Rated: Buy
Price Target: $37 → $31
Current: $6.16
Upside: +403.25%
COMPASS Pathways
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $12.53
Upside: +35.67%
Capricor Therapeutics
Mar 13, 2026
Rated: Buy
Price Target: $50 → $63
Current: $28.38
Upside: +121.99%
Ovid Therapeutics
Mar 10, 2026
Reiterated: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
Vanda Pharmaceuticals
Feb 25, 2026
Maintained: Buy
Price Target: $14 → $17
Current: $5.81
Upside: +192.85%
Fennec Pharmaceuticals
Feb 12, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $9.06
Upside: +76.60%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintained: Buy
Price Target: $61 → $101
Current: $81.82
Upside: +23.44%
Axsome Therapeutics
Oct 1, 2025
Initiated Coverage: Buy
Price Target: $179
Current: $250.50
Upside: -28.54%